 | Up a level |
Barco, Stefano; Virdone, Saverio; Götschi, Andrea; Ageno, Walter; Arcelus, Juan I; Bingisser, Roland; Colucci, Giuseppe; Cools, Frank; Duerschmied, Daniel; Gibbs, Harry; Fumagalli, Riccardo M; Gerber, Bernhard; Haas, Sylvia; Himmelreich, Jelle C L; Hobbs, Richard; Hobohm, Lukas; Jacobson, Barry; Kayani, Gloria; Lopes, Renato D; MacCallum, Peter; ... (2023). Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials. Thrombosis research, 230, pp. 27-32. Elsevier 10.1016/j.thromres.2023.08.009
Valgimigli, Marco; Garcia Garcia, Hector; Vrijens, Bernard; Vranckx, Pascal; McFadden, Eugène P; Costa, Francesco; Pieper, Karen; Vock, David M; Zhang, Min; Van Es, Gerrit-Anne; Tricoci, Pierluigi; Baber, Usman; Steg, Gabriel; Montalescot, Gilles; Angiolillo, Dominick J; Serruys, Patrick W; Farb, Andrew; Windecker, Stephan; Kastrati, Adnan; Colombo, Antonio; ... (2019). Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC). European Heart Journal, 40(25), pp. 2070-2085. Oxford University Press 10.1093/eurheartj/ehy377
